(Q39579677)

13 September 2017

HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of pleura (English)

1 reference

13 September 2017

Kennedy AD

1 reference

13 September 2017

King G

series ordinal

1 reference

13 September 2017

Kerr KM

series ordinal

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

Journal of Clinical Pathology

13 September 2017

1 reference

13 September 2017

1 reference

13 September 2017

1 reference

13 September 2017

859-862

1 reference

Mesothelioma-binding antibodies: thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesothelioma

13 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500270

A comparative immunohistochemical study of malignant mesothelioma and renal cell carcinoma: the diagnostic utility of Leu-M1, Ber EP4, Tamm-Horsfall protein and thrombomodulin

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500270

OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500270

Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500270

Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500270

ME1-antibody labelling of primary bronchogenic tumours and extrapulmonary malignancies

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500270

Ber-EP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500270

Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500270

The histopathological diagnosis of malignant mesothelioma v. pulmonary adenocarcinoma: reproducibility of the histopathological diagnosis.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500270

The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: the role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen, and mi

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500270

Immunohistochemical phenotype of malignant mesothelioma: predictive value of CA125 and HBME-1 expression

21 August 2018

1 reference

12 December 2020

Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma

1 reference

12 December 2020

Immunocytochemical study of Peyer's patches follicular-associated epithelium in the marsupial, Didelphis albiventris

1 reference

12 December 2020

Differentiation of adenocarcinoma of the lung and malignant mesothelioma: predictive value and reproducibility of immunoreactive antibodies

1 reference

12 December 2020

The diagnostic value of thrombomodulin immunolocalization in serous effusions

1 reference

12 December 2020

Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma

1 reference

12 December 2020

Calretinin: A Novel Immunocytochemical Marker for Mesothelioma

1 reference

12 December 2020

The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.50.10.859

1 reference

13 September 2017

1 reference

13 September 2017

PubMed publication ID

9462271

1 reference